Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
6.4
51.71%
60%
—
299x
80%
—
5 Years
Score6.4
Net Growth51.71%
Net Trend60%
Net Income Consistency—
Rev Growth299x
Rev Trend80%
Revenue Consistency—
Fennec Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 170K to $ 44M and net income went from -$ 18M to -$ 9M. Revenue increased in 4 of those 5 years; net income in 3.
Fennec Pharmaceuticals Inc currently holds a 5-year HDB Score of 6.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 11.83 | — |
1 Year2025-08-12 | $ 9.24 | 28.03% |
5 Years2021-08-12 | $ 7.14 | 65.69% |
10 Years2016-08-12 | $ 2.03 | 481.36% |
20 Years2006-08-11 | $ 18.36 | -35.57% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 |
|---|---|---|---|---|---|
| Price | $ 11.83 | $ 9.24 | $ 7.14 | $ 2.03 | $ 18.36 |
| Return | — | 28.03% | 65.69% | 481.36% | -35.57% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 50M | -$ 8M | $ 40M |
| 2025 | $ 44M | -$ 9M | $ 36M |
| 2024 | $ 47M | -$ 436K | $ 26M |
| 2023 | $ 21M | -$ 16M | $ 13M |
| 2022 | $ 1M | -$ 23M | $ 23M |
| 2021 | $ 170K | -$ 17M | $ 21M |
| 2020 | $ 170K | -$ 18M | $ 30M |
| 2019 | $ 0.00 | -$ 12M | $ 13M |
| 2018 | $ 0.00 | -$ 9M | $ 22M |
| 2017 | $ 0.00 | -$ 7M | $ 28M |
| 2016 | $ 0.00 | -$ 2M | $ 3M |
| 2015 | $ 0.00 | -$ 659K | $ 942K |
| 2014 | $ 0.00 | -$ 2M | $ 2M |
| 2013 | $ 0.00 | $ 1M | $ 1M |
| 2012 | $ 0.00 | -$ 5M | $ 2M |
| 2011 | $ 0.00 | $ 4M | $ 5M |
| 2010 | -$ 7M | $ 5M | |
| 2009 | -$ 3M | $ 685K | |
| 2008 | -$ 13M | $ 5M | |
| 2007 | -$ 13M | $ 16M | |
| 2006 | -$ 19M | $ 5M | |
| 2005 | -$ 19M | $ 13M | |
| 2003 | $ 0.00 | -$ 8M | $ 20M |
| 2002 | $ 0.00 | -$ 6M | $ 2M |
| IPO2001 | $ 0.00 | -$ 3M | $ 5M |
Explore beyond FENC
You're looking at Fennec Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
